Clinical Trial Update: Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating SAR408701 in Japanese patients with advanced malignant solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SAR408701

Snippet

Sponsor: Sanofi | Conditions: Neoplasm Malignant | Phase 1 | Status: COMPLETED